News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
594,835 Results
Type
Article (46046)
Company Profile (215)
Press Release (548574)
Section
Business (172084)
Career Advice (2509)
Deals (31766)
Drug Delivery (111)
Drug Development (75879)
Employer Resources (156)
FDA (16103)
Job Trends (13227)
News (304351)
Policy (31746)
Tag
Academia (2353)
Alliances (43021)
Alzheimer's disease (1302)
Approvals (16012)
Artificial intelligence (134)
Bankruptcy (313)
Best Places to Work (9830)
Biotechnology (115)
Breast cancer (120)
Cancer (1070)
Cardiovascular disease (97)
Career advice (2098)
Cell therapy (239)
Clinical research (60313)
Collaboration (364)
Compensation (201)
COVID-19 (2593)
C-suite (94)
Data (1054)
Diabetes (157)
Diagnostics (5357)
Drug pricing (99)
Earnings (67286)
Employer resources (142)
Events (89125)
Executive appointments (293)
FDA (16636)
Funding (303)
Gene therapy (187)
GLP-1 (662)
Government (3879)
Healthcare (15353)
Infectious disease (2680)
Inflammatory bowel disease (106)
Interviews (459)
IPO (14874)
Job creations (3753)
Job search strategy (1762)
Layoffs (457)
Legal (7652)
Lung cancer (177)
Manufacturing (185)
Medical device (11280)
Medtech (11284)
Mergers & acquisitions (16971)
Metabolic disorders (456)
Neuroscience (1588)
NextGen Class of 2024 (5262)
Non-profit (3311)
Northern California (1392)
Obesity (267)
Opinion (212)
Patents (106)
People (50134)
Phase I (18053)
Phase II (26257)
Phase III (20863)
Pipeline (460)
Policy (88)
Postmarket research (2538)
Preclinical (7490)
Radiopharmaceuticals (221)
Rare diseases (222)
Real estate (5192)
Regulatory (21572)
Research institute (2179)
Resumes & cover letters (415)
Southern California (1203)
Startups (3231)
United States (12374)
Vaccines (624)
Weight loss (218)
Date
Today (130)
Last 7 days (726)
Last 30 days (3635)
Last 365 days (33557)
2024 (30805)
2023 (37220)
2022 (47704)
2021 (51387)
2020 (48653)
2019 (39202)
2018 (29904)
2017 (30548)
2016 (29175)
2015 (32677)
2014 (26562)
2013 (22192)
2012 (23752)
2011 (24429)
2010 (22346)
Location
Africa (757)
Arizona (152)
Asia (36651)
Australia (5988)
California (3076)
Canada (1100)
China (217)
Colorado (138)
Connecticut (161)
Europe (83575)
Florida (435)
Georgia (101)
Illinois (289)
Indiana (168)
Maryland (552)
Massachusetts (2455)
Michigan (124)
Minnesota (221)
New Jersey (903)
New York (865)
North Carolina (692)
Northern California (1392)
Ohio (114)
Pennsylvania (765)
South America (1131)
Southern California (1203)
Texas (419)
Washington State (337)
594,835 Results for "veloxis pharmaceuticals a s".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Bio NC
Veloxis Pharmaceuticals Selected to Present at the 2024 American Transplant Congress in Philadelphia
Veloxis Pharmaceuticals, Inc. is pleased to announce the presentation of VEL-101 research at the 2024 American Transplant Congress (ATC).
May 30, 2024
·
5 min read
Bio NC
Lyfebulb and Veloxis Pharmaceuticals Announce Finalists for 2022 Innovation Challenge in Organ Transplantation
Lyfebulb, a patient-empowerment platform that connects patients with industry experts to support user-driven innovation, and Veloxis Pharmaceuticals, a fully integrated specialty pharmaceutical company, are pleased to announce 10 finalists for the 2022 “Transforming Organ Transplantation Through Innovation” Challenge.
September 19, 2022
·
4 min read
Bio NC
Biohope and C. Alan Foundation Named Winners of the 2022 Lyfebulb-Veloxis Innovation Challenge: Transforming Organ Transplantation
Lyfebulb and Veloxis Pharmaceuticals are excited to announce that Biohope was selected as the winner of the Innovation Award and C. Alan Foundation as the winner of the Impact Award at the 2022 Lyfebulb-Veloxis Innovation Challenge: Transforming Organ Transplantation.
October 17, 2022
·
4 min read
Bio NC
Lyfebulb and Veloxis Pharmaceuticals Seek Applicants for the Global 2022 Innovation Challenge in Organ Transplantation
Lyfebulb, a patient-empowerment platform that connects patients with industry experts to support user-driven innovation, and Veloxis Pharmaceuticals, an Asahi Kasei, fully integrated specialty pharmaceutical company, invite entrepreneurs to apply to their “Transforming Organ Transplantation Through Innovation” Challenge.
July 26, 2022
·
4 min read
Neurodegenerative disease
7 Alzheimer’s and Parkinson’s Programs Discarded in 2024
This year has seen several biopharma companies drop Alzheimer’s and Parkinson’s disease programs, but experts say plenty are still chasing these multi-billion-dollar markets.
November 4, 2024
·
6 min read
·
Heather McKenzie
Press Releases
NINER Pharmaceutical Launches Strategic Initiative to Address IV Fluid Shortages in the U.S. and Latin America
November 21, 2024
·
2 min read
Cell and gene therapy
Big Pharma’s Interest Grows in Evolving Cell and Gene Therapy Sector
Large pharmaceutical companies were out in force at this week’s 2024 Cell & Gene Meeting on the Mesa, as they look to expand their presence in the industry.
October 9, 2024
·
4 min read
·
Greg Slabodkin
Press Releases
Meitheal Pharmaceuticals Secures Exclusive Commercial Licensing Agreement for Three Biosimilars in the U.S.
October 31, 2024
·
5 min read
Press Releases
Lipella Pharmaceuticals Secures Extended Market Exclusivity with Issuance of U.S. Patent for Liposomal Delivery Platform
November 12, 2024
·
3 min read
ADCs
rADCs Could Take Cancer Treatment ‘Magic Bullet’ to a New Level
Pharmaceutical companies are combining antibodies with radioisotopes in a bid to more precisely deliver radiation to cancers and tumors.
October 21, 2024
·
6 min read
·
Sruthi S. Balakrishnan
1 of 59,484
Next
